Explore Stanford technologies available for licensing:

Technology Reference
CZ Biohub ref. no. CZB-177S
Stanford ref. no. S20-303

Researchers at Stanford have developed a method for real-time wireless resistive sensing using non-linear PT-symmetry.

Stanford scientists developed a comprehensive, minimally invasive, dual-catheter pulsed field device that utilizes a rapid and simple integrated mapping/ablation strategy for the treatment of Atrial Fibrillation.

Stanford inventors have created a novel, interactive, highly scalable computational approach for representing dynamic brain activity as a network for use in clinical settings.

Researchers at Stanford University have developed a bespoke method for multiplexing beads in bioassays that expands the possible coding space when compared to available bead barcoding technologies.

Stanford inventors have developed an information theoretic, seizure detection algorithm for electroencephalography (EEG) towards improving diagnosis, management, and treatment of patients with epilepsy.

Researchers at Stanford have invented a novel hydrogel with enhanced retention and extended durability. This hydrogel can be held together three times longer than many alternatives without sacrificing its self-healing attributes during injection.

Researchers from Stanford University have developed an algorithm for electromagnetic device prototyping which optimizes geometric shape based on physical functionality.

Researchers at Stanford, Yale, Rutgers, and the Karolinska Institute (Sweden) have developed a rapid and cheap method to detect genetic material from pathogenic infections (viral, bacterial, etc.) using electrical impedance measurement of amplified DNA nanoballs.

Researchers at Stanford have developed a novel cell-free stem cell derived extracellular vesicle (EV) therapy powered by pulsed focused ultrasound (pFUS) that enhances its therapeutic and bioenergetic effect.

Stanford researchers have developed an active photonic metasurface with fast and high-resolution optical control for light modulation devices.

Stanford researchers have developed two novel, minimally invasive neochordal devices for mitral valve repair.

Stanford scientists have invented a new suite of adaptable hydrogel biomaterials that are optically transparent and injectable for cell encapsulation, tissue engineering, and drug delivery.

The Hu Lab at Stanford has identified several FDA-approved small molecule medicines with neuroprotective effects on glaucoma.

Disease indication -Acute asthma, COPD, other bronchoconstrictive disorders (bronchial asthma, allergic asthma, intrinsic asthma, airway hyper-responsiveness, chronic bronchitis) with potential for treating heart failure.

Researchers at Stanford have developed a methodology for deep learning-based image reconstruction by incorporating the physics or geometry priors of the imaging system with deep neural networks.